Ranbaxy Laboratories
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company. Founded in 1961, it was once one of India's largest pharmaceutical companies, known for its extensive generic drug portfolio and significant presence in both domestic and international markets. Ranbaxy focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations, including generics and branded products across various therapeutic areas. The company played a substantial role in making affordable medicines accessible to a larger population. However, Ranbaxy faced significant challenges, including regulatory issues and accusations of data integrity problems, ultimately leading to its acquisition by Sun Pharmaceutical Industries in 2015. Its operations and assets were subsequently integrated into Sun Pharma.
About Us
- Ranbaxy Laboratories Limited, established in 1961, pioneered the Indian pharmaceutical industry by manufacturing and supplying essential medicines. - The company expanded to include robust R&D, creating innovative and affordable healthcare solutions, significantly impacting medication accessibility for millions. - Ranbaxy's growth involved organic expansion and strategic acquisitions, leading to a substantial global presence with diverse products across various therapeutic segments. - Its commitment was to generic drug development. - Though no longer independent, Ranbaxy's history is a notable chapter in India's pharmaceutical journey.
Vision
Similarly to its mission, Ranbaxy's vision, though not explicitly documented publicly, likely encompassed becoming a leading global player in the pharmaceutical industry, renowned for its commitment to both affordable generic medication and, at times, innovative drug development. It aimed to improve global healthcare access by making essential medications readily available.
Mission
While a precise, formally stated mission statement for Ranbaxy from its independent existence is difficult to definitively confirm without access to archived internal documents, its actions indicated a mission centered around providing affordable and high-quality medicines to a global population. This implicitly involved investing in research and development, efficiently manufacturing medications, and ensuring widespread access through effective distribution networks.
Culture
- Ranbaxy's corporate culture, though undocumented, likely emphasized innovation in R&D and cost-effective manufacturing. - The company prioritized expanding its market reach globally. - Ranbaxy's rapid growth indicates a culture of ambition and adaptability.
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities